← Leaderboards
Ryan Kelly
Micromics Technologies Llc
$2,455,000
Attributed
$2,455,000
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2021–23$2M$1.5M$1M$500K$0
'21
'22
'23
Funding mix
By agency
NIH$2,455,000 · 2
By mechanism
N44$2,000,000 · 1
N43$455,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsSamplingSmall Business Innovation Research GrantProteinsPreparationProteomeRecoveryCustomBiological SystemsLiquid Chromatography Mass SpectrometryCancer DiagnosticsData QualityOpen SourceHela CellsAnticancer ResearchPerformanceMeasurementManualsInstrumentComputer SoftwareCostNeoplasm Circulating CellsNanolitreImpairment
Grant awards (3)
SBIR PHASE II, TOPIC 420: INTEGRATED PLATFORM AND CONSUMABLES FOR ROBUST, SENSITIVE AND HIGH-THROUGHPUT SINGLE-CELL PROTEOMICS$2,000,000
N44 · FY2023 · CA · contact PI
TOPIC 420 INTEGRATED PLATFORM FOR IN-DEPTH SINGLE-CELL PROTEOMICSPERIOD OF PERFORMANCE SEPTEMBER 13, 2021-JUNE 12, 2022FY21 PHASE I SBIR$55,000
N43 · FY2022 · CA · contact PI
TOPIC 420 INTEGRATED PLATFORM FOR IN-DEPTH SINGLE-CELL PROTEOMICSPERIOD OF PERFORMANCE SEPTEMBER 13, 2021-JUNE 12, 2022FY21 PHASE I SBIR$400,000
N43 · FY2021 · CA · contact PI